Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
We evaluate ETFs that minimize taxes on retirement income, aiming to boost net returns while controlling tax impact on withdrawals.
23,314 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
New data shows high-end metro areas are turning over listings faster than mid-priced markets, upending expectations a...
Investors are weighing the latest earnings from First Majestic Silver. This article breaks down what the numbers mean...
Brookfield Corporation just bought back a substantial amount of its own stock. The move raises questions about whethe...
Embark on a cinematic journey that blends iconic storytelling with practical money moves. This guide highlights 11 mu...
As investors scan early 2026 results, worksport (WKSP) 2026 earnings reveal how a niche hardware maker navigates supp...
Devon Energy shares surged after an updated 2026 forecast highlighted stronger cash flow and a solid balance sheet. T...
When a hot brand makes a big move, smart investors look for durable opportunities in the S&P 500. Here are three stoc...
As the Fed gears up for a leadership transition, two distinct paths a new chair could take threaten to rattle a histo...
Adobe's 2026 earnings trajectory hinges on subscription momentum, AI-enabled products, and disciplined costs. This gu...
Discretionary travel names like these cruise line stocks are feeling the strain as fuel prices rise and traveler dema...
The Federal Reserve's May inflation forecast signals higher costs and tougher markets ahead. This guide breaks down w...